Objectives: To evaluate clinical, demographic, and surgical factors that may be associated with mesh exposure after vaginal repair of pelvic organ prolapse (POP).
T he use of mesh for vaginal prolapse repair, whether the abdominal or vaginal route, has improved anatomic results compared to native tissue plication techniques. 1Y3 However, concerns regarding lack of safety and efficacy data on vaginal prolapse repair with mesh have contributed to a 2011 United States Food and Drug Administration (FDA) public health notification regarding ''serious complications associated with transvaginal placement of surgical mesh in repair of pelvic organ prolapse (POP) and stress urinary incontinence,'' 4 specifically identifying vaginal mesh exposure.
Previous studies of abdominal sacrocolpopexy have suggested risk factors for mesh exposure to be current smoking, concurrent hysterectomy, and certain types of mesh usage. 5 A recent meta-analysis of vaginal prolapse repair with mesh reported a 10.3% mesh exposure rate, 6 with risk factors including young age, smoking, diabetes, inverted ''T'' incision, and increased sexual activity. 6, 7 Others suggest that surgical experience and improved technique may decrease vaginal mesh exposure. 8, 9 We present our experience with the Prolift (Ethicon, Sommerville, NJ) and Elevate (American Medical Systems, Minnetonka, MN) vaginal mesh techniques in a urology training program over a 6-year period. We evaluated patients' baseline clinical and demographic data and operative and postoperative variables for associations with vaginal mesh exposure.
MATERIALS AND METHODS
After institutional review board approval, a retrospective chart review was performed of patients who underwent POP repair with the Prolift system between 2006 and 2009 and Elevate system from 2009 to 2011 at a single teaching institution by 4 fellowshiptrained urologists. Patients who had transvaginal repair of POP with mesh were identified from hospital and physician office billing records. Routine follow-up examinations were conducted at 2 weeks, 3 and 6 months postoperatively, and yearly by the operating surgeon to assess surgical site and examine for mesh exposure. Research funding was provided by philanthropy from a private donor who has supported research projects and other programs in our department for more than a decade. American Medical Systems, Inc (AMS) also provided funding through their investigator-sponsored research grant mechanism, but AMS had no input into protocol development, analysis, or reporting of findings.
Surgical technique included initial saline hydrodissection and anterior vaginal incision to create thick vaginal flaps, and tunneling under intact mucosa to the apex. With concurrent hysterectomy, care was taken not to create a T incision. Standard Prolift and Elevate surgical techniques were used, and the anterior Prolift was commonly modified to correct both anterior and apical compartment with fixation of the apical arms to the sacrospinous ligaments. Redundant vaginal mucosa was not trimmed, and incisions were closed with running absorbable suture. All surgeons used vaginal packing that was removed the first postoperative morning.
Patients' clinical and demographic data including body mass index (BMI), parity, smoking history, diabetes, previous vaginal surgery, menopausal status, history of steroid and hormonal replacement therapy were tested for association with overall mesh exposure and in the Prolift and Elevate subgroups. Prolapse grade was quantified using the Baden-Walker prolapse classification system. Operative data including compartment repaired, concurrent hysterectomy, sling placement, operative time, and adjacent organ injury were recorded. Postoperative variables evaluated included standardized pain scores (standard nursing protocol reported on a 0-to-10 scale), narcotic use (converted to morphine equivalents using published tables), 10 and change in hemoglobin ($Hgb = preoperative Hgb minus postoperative nadir Hgb). Length of time since follow-up was calculated as surgical date to the date all clinic records were reviewed (September 2011), and surgical date to last office visit date. Categorical variables are reported as counts and percent frequencies. They were examined using Pearson W2 test where appropriate (expected frequency, 95); otherwise, the Fisher exact test was used. The continuous variables were examined using Wilcoxon rank sum tests owing to lack of normality and the small number of patients in the mesh group. All continuous variables are reported as means T SD followed by the (median) or the median and range where needed. Multivariable step-down logistic regression was also completed to examine predictors of mesh exposure. All analyses used SAS for Windows version 9.2 (Cary, NC).
RESULTS
Vaginal prolapse repair with mesh was performed in 335 women from 2006 to 2011: Elevate in 71 women (21%) and Prolift in 264 women (79%). Vaginal mesh exposure was identified in 27 (8.1%) of 335 women: 21 (8.0%) of 264 women after Prolift and 6 (8.5%) of 71 women after Elevate (P = 0.89). The median time to mesh exposure was 96 days (15Y1129 days). Subject follow-up rate by length of time from surgery to last office visit was less than 6 weeks in 56 (17%) of 332 women, 6 weeks to 6 months in 130 (39%) of 332 women, and more than 6 months in 146 (44%) of 332 women.
The mesh exposure group had longer median follow-up than the no exposure group (357 vs 145 days; P = 0.0003), and the Prolift group had longer median follow-up than the Elevate group (186 vs 94 days; P G 0.0001). Evaluation of clinical and demographic variables revealed that patients with mesh exposure had lower BMI (25.2 T 2.5 vs 27.4 T 5.1; P = 0.020), but mesh exposure was not associated with age, menopausal status, smoking, diabetes, steroid use, prolapse grade, or prior surgery (Table 1) . Change in Hgb ($Hgb) was calculated for the patients who had both a preoperative and postoperative Hgb measurement (286 and 25 women in the exposure/no exposure groups, respectively). For patients who had more than one postoperative value, the postoperative nadir was used to calculate $Hgb. Evaluation of surgical and perioperative data revealed that mesh exposure was associated with greater $Hgb (j3.7 T 1.7 mg/dL vs j2.5 T1.3; P = 0.0011; Table 2 ) but was not associated with compartment repaired, concurrent hysterectomy, or bladder injury. A step-down logistic regression analysis found only a drop in hemoglobin and longer length of follow-up to be the significant predictors of mesh exposure in this group of patients (P = 0.0090 and P = 0.0023, respectively).
Procedures were analyzed by year of surgery to determine the effect of surgeon's experience on mesh exposure (Fig. 1) . Mesh exposure decreased from 16.7% (2/12) in 2005 to 12.2% (10/82) in 2006 and then was stable in years 2007Y2011 at a range of 4.4% to 7.7%. However, this decline was not statistically significant (P = 0.49). Change in Hgb was found to be greatest in the first 2 years of experience, 2005 and 2006: j2.97 T 1.3 and j3.32 T 1.5, respectively. The $Hgb was significantly less in the years 2007Y2011, with a range of j2.26 T 1.0 to j2.47 T 1.6; P = 0.0005 (Fig. 2) .
DISCUSSION
This study demonstrates that operative bleeding is a significant risk factor for mesh exposure after vaginal prolapse surgery. We hypothesize that pelvic bleeding drains through the anterior vaginal wall incision, resulting in vaginal epithelial separation and subsequent mesh exposure. Although not statistically significant, we also observed a trend that the mesh exposure rate decreased after the first 2 years of our surgical experience (16.7% and 12.2%) and remained stable over the subsequent 5 years (range, 4.4%Y7.7%). The lack of statistical significance over time may be due to fewer procedures in the first 2 years, the low number of mesh exposure overall, or the shorter length of follow-up for Elevate.
The decreased blood loss observed after our early experience may account for the decreased mesh exposure rate; however, there may have been other experience-based technical improvements, including increased use of saline hydrodissection to develop thick vaginal flaps for coverage, and no trimming of vaginal mucosa as often done after primary midline plication. Others have reported similar observation of a significant decrease in blood loss over the first 2 years of surgical experience, as well as decreased mesh exposure. 8 Aggressive vaginal packing may minimize blood drainage through the vaginal incision and decrease vaginal epithelial separation. In this study, all of our surgeons used postoperative vaginal packing, but the tension of the packing is a variable that was not evaluated. It remains unclear whether there are other nonmodifiable mesh-specific factors associated with exposure.
The association of mesh exposure with lower BMI in this study is difficult to explain. Traditionally, obese patients are more technically challenging, and higher BMI has been associated with increased blood loss and surgical complications with an abdominal approach, including bladder and ureteral injury. 11 Whether the association of vaginal mesh exposure with lower BMI in this study reflects a statistical error from the small number of patients with mesh exposure and the large number of variables in this analysis, or some other as of yet unrecognized phenomenon is uncertain. Although others have reported increased risk of mesh exposure with age, smoking, and diabetes, 12 we did not identify an association with any of these variables.
Specific surgical procedures such as concurrent hysterectomy and rectocele repair have been reported to increase the risk of mesh exposure. 8 However, we did not observe any association of mesh exposure in our relatively large cohorts of women with concurrent hysterectomy (n = 89), or with mesh placed in the posterior compartment (n = 139). It is unclear what role our surgical techniques of using a small anterior vaginal incision that does not ''T'' into the apical hysterectomy incision, or of the transverse posterior compartment incision with tunneling under the mucosa to the apex, have in these findings.
The overall 8% rate of vaginal mesh exposure in this study is comparable to the 10.3% rate reported in a recent meta-analysis of the literature. 6 We did not observe any difference in mesh exposure rates between the Elevate and the Prolift surgical techniques. This should reassure pelvic surgeons that vaginal placement of mesh anchored to the sacrospinous ligaments using either trocar-based or nonYtrocar-based techniques have equivalent mesh exposure rates. The similar nature of these 2 meshes may be more important than their placement method. Similar conclusions cannot be drawn from other mesh systems that may have different mesh characteristics.
A strength of the study is the large number of patients and inclusion of 4 fellowship-trained surgeons in a urology teaching program, which make the findings generalizable. Limitations include potential bias associated with retrospective chart review. In addition, with longer mean follow-up, we may observe more mesh exposure. However, in our experience, we identified mesh exposure at a median of 96 days, well under the median follow-up in this study. Longer follow-up is ongoing and necessary to establish if the rate increases and if there are other factors associated with vaginal mesh exposure. Another limitation of our study is that there may have been patients with a mesh exposure who did not return to our institution but sought care elsewhere. These exposures would not have been captured through chart review. Finally, the large number of variables tested against a small number of mesh exposures may find an association by chance alone.
In conclusion, we identified an association between both lower BMI and a decrease in hemoglobin with vaginal mesh exposure. The extent of bleeding and incidence of mesh exposure decreased after two years of experience. The results of this study should reassure surgeons that there is no difference in the mesh exposure rates of the trocar-based Prolift and nonYtrocar-based Elevate techniques; however, more research and longer follow-up are needed to confirm these findings. These data reinforce the opinion that vaginal prolapse repair with mesh can be safely done with experienced pelvic surgeons.
